XML 116 R101.htm IDEA: XBRL DOCUMENT v3.22.4
EARNINGS PER SHARE AND EQUITY - Narrative (Details)
$ / shares in Units, $ in Millions
12 Months Ended
Aug. 01, 2022
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
$ / shares
shares
Class of Warrant or Right [Line Items]      
Antidilutive shares excluded from the calculation of diluted EPS (in shares)   586,269  
Convertible common stock, conversion ratio 1    
Common stock, shares outstanding (in shares) 99,387,467 99,445,074  
Common stock, shares issued (in shares) 99,387,467 99,445,074  
Granted (in shares)   14,647,307  
Strike price (dollars per share) | $ / shares $ 2.76   $ 0
Stock options issued (in shares)   14,394,835 0
Exercise price (in dollars per share) | $ / shares   $ 5.01 $ 0
Weighted average remaining contractual term, exercisable   7 years 7 months 6 days  
Fair value of warrants | $   $ 9.8  
Director      
Class of Warrant or Right [Line Items]      
Granted (in shares)   15,000  
Series I Warrant      
Class of Warrant or Right [Line Items]      
Number of common shares called by warrants (in shares) 3,342,566    
Exercise price (in dollars per share) | $ / shares $ 10.00    
Series II Warrant      
Class of Warrant or Right [Line Items]      
Number of common shares called by warrants (in shares) 3,342,566    
Exercise price (in dollars per share) | $ / shares $ 0.01    
Stock options      
Class of Warrant or Right [Line Items]      
Granted (in shares) 10,900,000    
Expiration period 10 years